## Abstract ## BACKGROUND Cisplatinβbased combinations are considered to be the standard treatment for advanced transitional cell carcinoma (TCC) of the urothelium. Many of the patients are elderly with concomitant diseases or impaired renal function. We studied the tolerance and activity of the g
β¦ LIBER β¦
Gemcitabine-induced vasculitis in advanced transitional cell carcinoma of the bladder
β Scribed by M. Birlik; S. Akar; E. Tuzel; F. Onen; E. Ozer; M. Manisali; Z. Kirkali; N. Akkoc
- Publisher
- Springer-Verlag
- Year
- 2004
- Tongue
- English
- Weight
- 448 KB
- Volume
- 130
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Gemcitabine and carboplatin in advanced
β
Miquel NoguΓ©-Aliguer; Joan Carles; Antonio Arrivi; Oscar Juan; Lorenzo Alonso; A
π
Article
π
2003
π
John Wiley and Sons
π
English
β 89 KB
Combined radiation and chemotherapy for
β
Gerhard Jakse; Herman Frommhold; Dieter Zur Nedden
π
Article
π
1985
π
John Wiley and Sons
π
English
β 528 KB
Transitional cell papillary carcinoma of
β
B. Lalmand; E. F. Avni; J. Simon; A. Verhest; C. C. Schulman; J. Struyven
π
Article
π
1987
π
Springer-Verlag
π
English
β 360 KB
Meningeal carcinomatosis from transition
β
Charis Eng; David Cunningham; Bradley J. Quade; Lee Schwamm; Philip W. Kantoff;
π
Article
π
1993
π
John Wiley and Sons
π
English
β 528 KB
Neoadjuvant methotrexate, vinblastine, d
β
Ralph J. Miller Jr.; Robert R. Bahnson; Barbara Banner; Marc S. Ernstoff; Walter
π
Article
π
1990
π
John Wiley and Sons
π
English
β 376 KB
π 2 views
Chemotherapy of advanced transitional ce
β
Frank M. Torti; W. Graydon Harker
π
Article
π
1983
π
Springer
π
English
β 390 KB
Activity has been demonstrated for both single agents and combination chemotherapy in advanced transitional cell carcinoma of the uroepithelium. Regimens are palliative; duration of response has been modest, usually ranging from 3 to 8 months. There are few complete responders; occasional patients r